• Breast Cancer mix up of medication..FDA Breaking News

    Asked by CAS1 on Monday, May 6, 2013

    Breast Cancer mix up of medication..FDA Breaking News

    FDA: Name confusion could cause mix-up of two breast cancer drugs

    The FDA is alerting health care professionals of possible medication errors resulting from confusing generic names for Kadcyla (ado-trastuzumab emtansine) and Herceptin (trastuzumab).

    0 Answers from the Community

    Help the community by answering this question:

    Create an account to post your answer Already have an account? Sign in!

    By using WhatNext, you agree to our User Agreement, and Privacy Policy


    Read and answer more lung cancer questions.  Also, don't forget to check out our Lung Cancer page.